Showing results (1-10 of 220) with videos related to
Sort By:
Pageof 22
Preventive Medicine|January 1, 1991
Organizing multicenter trials: lessons from the cooperative oncology groupsP P Carbone, D C TormeyCancer Treatment Reports|October 1, 1977
Implications of the 99mTc diphosphonate bone scan on treatment of primary breast cancerD L Citrin, D C Tormey, P P CarboneAmerican Journal of Clinical Oncology|June 1, 1989
Combined modality treatment of local regionally advanced breast cancer patients. 5 to 10 year follow-upC L Loprinzi, P W Rasmussen, D C Tormey, et al.Breast Cancer Research and Treatment|January 1, 1985
Short term high density systemic therapy for metastatic breast cancerD C Tormey, J C Kline, M Palta, et al.Cancer|July 15, 1985
The Eastern Cooperative Oncology Group experience with cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in patients with metastatic breast cancerG Falkson, R S Gelman, D C Tormey, et al.Cancer|May 1, 1978
A randomized comparative trial of adriamycin versus methotrexate in combination drug therapyJ M Bull, D C Tormey, S H Li, et al.Cancer|January 15, 1990
Adjuvant chemohormonal therapy with cyclophosphamide, methotrexate, 5-fluorouracil, and prednisone (CMFP) or CMFP plus tamoxifen compared with CMF for premenopausal breast cancer patients. An Eastern Cooperative Oncology Group trialD C Tormey, R Gray, K Gilchrist, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1984
Aggressive combined modality therapy for advanced local-regional breast carcinomaC L Loprinzi, P P Carbone, D C Tormey, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1985
Adjuvant CMFP versus CMFP plus tamoxifen versus observation alone in postmenopausal, node-positive breast cancer patients: three-year results of an Eastern Cooperative Oncology Group studyS G Taylor, L A Kalish, J E Olson, et al.Pageof 22